Successful Steroid Treatment of Pembrolizumab-induced Agranulocytosis That Developed after Splenectomy in a Patient with Non-small-cell Lung Cancer

Neutropenia, a rare immune-related adverse event, affects patients receiving treatment with immune checkpoint inhibitors (ICIs). We herein report a case of pembrolizumab-induced agranulocytosis. An 83-year-old man was diagnosed with advanced-stage lung carcinoma concomitant with splenomegaly complic...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuzumi, Shinichi, Kamata, Hirofumi, Emoto, Katsura, Shimizu, Takayuki, Otake, Shiro, Irie, Hidehiro, Chubachi, Shotaro, Ikemura, Shinnosuke, Yasuda, Hiroyuki, Fukunaga, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400385/
https://www.ncbi.nlm.nih.gov/pubmed/36450461
http://dx.doi.org/10.2169/internalmedicine.0278-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400385/
https://www.ncbi.nlm.nih.gov/pubmed/36450461
http://dx.doi.org/10.2169/internalmedicine.0278-22

Ejemplares similares